Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-20-053871

Options or other derivatives

  • Director acquired 77,805 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Huang Andong · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-10-05 Grant or award : show line 1 in the form Stock Option (Right to Buy) +77,805 $0.51 $40,000 77,805 D
Loading xslF345X03/doc4.xml…